Cargando…

重组活化凝血因子Ⅶ联合凝血酶原复合物在血友病A伴高滴度抑制物患者围手术期的应用

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595871/
https://www.ncbi.nlm.nih.gov/pubmed/33113612
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.09.013
_version_ 1783601978228604928
collection PubMed
description
format Online
Article
Text
id pubmed-7595871
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-75958712020-10-30 重组活化凝血因子Ⅶ联合凝血酶原复合物在血友病A伴高滴度抑制物患者围手术期的应用 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2020-09 /pmc/articles/PMC7595871/ /pubmed/33113612 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.09.013 Text en 2020年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 短篇论著
重组活化凝血因子Ⅶ联合凝血酶原复合物在血友病A伴高滴度抑制物患者围手术期的应用
title 重组活化凝血因子Ⅶ联合凝血酶原复合物在血友病A伴高滴度抑制物患者围手术期的应用
title_full 重组活化凝血因子Ⅶ联合凝血酶原复合物在血友病A伴高滴度抑制物患者围手术期的应用
title_fullStr 重组活化凝血因子Ⅶ联合凝血酶原复合物在血友病A伴高滴度抑制物患者围手术期的应用
title_full_unstemmed 重组活化凝血因子Ⅶ联合凝血酶原复合物在血友病A伴高滴度抑制物患者围手术期的应用
title_short 重组活化凝血因子Ⅶ联合凝血酶原复合物在血友病A伴高滴度抑制物患者围手术期的应用
title_sort 重组活化凝血因子ⅶ联合凝血酶原复合物在血友病a伴高滴度抑制物患者围手术期的应用
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595871/
https://www.ncbi.nlm.nih.gov/pubmed/33113612
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.09.013
work_keys_str_mv AT zhòngzǔhuóhuàníngxuèyīnziviiliánhéníngxuèméiyuánfùhéwùzàixuèyǒubìngabàngāodīdùyìzhìwùhuànzhěwéishǒushùqīdeyīngyòng
AT zhòngzǔhuóhuàníngxuèyīnziviiliánhéníngxuèméiyuánfùhéwùzàixuèyǒubìngabàngāodīdùyìzhìwùhuànzhěwéishǒushùqīdeyīngyòng
AT zhòngzǔhuóhuàníngxuèyīnziviiliánhéníngxuèméiyuánfùhéwùzàixuèyǒubìngabàngāodīdùyìzhìwùhuànzhěwéishǒushùqīdeyīngyòng
AT zhòngzǔhuóhuàníngxuèyīnziviiliánhéníngxuèméiyuánfùhéwùzàixuèyǒubìngabàngāodīdùyìzhìwùhuànzhěwéishǒushùqīdeyīngyòng
AT zhòngzǔhuóhuàníngxuèyīnziviiliánhéníngxuèméiyuánfùhéwùzàixuèyǒubìngabàngāodīdùyìzhìwùhuànzhěwéishǒushùqīdeyīngyòng
AT zhòngzǔhuóhuàníngxuèyīnziviiliánhéníngxuèméiyuánfùhéwùzàixuèyǒubìngabàngāodīdùyìzhìwùhuànzhěwéishǒushùqīdeyīngyòng
AT zhòngzǔhuóhuàníngxuèyīnziviiliánhéníngxuèméiyuánfùhéwùzàixuèyǒubìngabàngāodīdùyìzhìwùhuànzhěwéishǒushùqīdeyīngyòng
AT zhòngzǔhuóhuàníngxuèyīnziviiliánhéníngxuèméiyuánfùhéwùzàixuèyǒubìngabàngāodīdùyìzhìwùhuànzhěwéishǒushùqīdeyīngyòng
AT zhòngzǔhuóhuàníngxuèyīnziviiliánhéníngxuèméiyuánfùhéwùzàixuèyǒubìngabàngāodīdùyìzhìwùhuànzhěwéishǒushùqīdeyīngyòng
AT zhòngzǔhuóhuàníngxuèyīnziviiliánhéníngxuèméiyuánfùhéwùzàixuèyǒubìngabàngāodīdùyìzhìwùhuànzhěwéishǒushùqīdeyīngyòng
AT zhòngzǔhuóhuàníngxuèyīnziviiliánhéníngxuèméiyuánfùhéwùzàixuèyǒubìngabàngāodīdùyìzhìwùhuànzhěwéishǒushùqīdeyīngyòng
AT zhòngzǔhuóhuàníngxuèyīnziviiliánhéníngxuèméiyuánfùhéwùzàixuèyǒubìngabàngāodīdùyìzhìwùhuànzhěwéishǒushùqīdeyīngyòng